Jasmine Blevins, RN | |
770 Woodlane Rd, Westampton, NJ 08060-3804 | |
(609) 267-5928 | |
Not Available |
Full Name | Jasmine Blevins |
---|---|
Gender | Female |
Speciality | Counselor - Mental Health |
Location | 770 Woodlane Rd, Westampton, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053906446 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WA0400X | Registered Nurse - Addiction (substance Use Disorder) | 26NR21937900 (New Jersey) | Secondary |
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jasmine Blevins, RN 770 Woodlane Rd, Westampton, NJ 08060-3804 Ph: (609) 267-5928 | Jasmine Blevins, RN 770 Woodlane Rd, Westampton, NJ 08060-3804 Ph: (609) 267-5928 |
News Archive
Researchers at The University of Texas at Austin have developed a new approach to treating cancer using enzyme therapy.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today the publication of a clinical guide by the European Menopause and Andropause Society (EMAS) in its journal Maturitas on lichen sclerosus with summary recommendations.
Agfa HealthCare today reports the Defense Logistics Agency (DLA) has awarded the company a contract to implement and support its enterprise diagnostic imaging solution, IMPAX. IMPAX is Agfa HealthCare's advanced solution for diagnostic radiology imaging, including tools to improve workflow, analysis, and operations for medical imaging management and collaboration.
TGen Clinical Research Services at Scottsdale Healthcare (TCRS) is the world's first clinical trials site for a new drug designed to halt cancer cell division.
› Verified 5 days ago